Drug intelligence / Profile preview

Sanwei Gushang Capsule

Development stage: Unknown
Lead developer: Gansu Heihong Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Sanwei Gushang Capsule is a Traditional Chinese Medicine (TCM) developed and manufactured by Gansu Heihong Pharmaceutical Co., Ltd. It is a multi-ingredient formulation primarily composed of three key active components: *Panax notoginseng* (Sanqi), *Carthamus tinctorius* (Honghua), and *Borneolum Syntheticum* (Bingpian). The capsule is indicated for the treatment of bone fractures, including distal radius fractures, by promoting blood circulation, resolving blood stasis, and providing analgesic and anti-inflammatory effects. It is approved in China for clinical use to accelerate the healing process and reduce localized swelling and pain associated with traumatic bone injuries.

Brand names: Sanwei Gushang Capsule
Other names: Sanwei Gushang Jiaonang三味骨伤胶囊

Beyond the preview

Go deeper on Sanwei Gushang Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanwei Gushang Capsule.

Explore the full profile